221 related articles for article (PubMed ID: 32168416)
1. Oridonin inhibits the migration and epithelial-to-mesenchymal transition of small cell lung cancer cells by suppressing FAK-ERK1/2 signalling pathway.
Xu L; Bi Y; Xu Y; Zhang Z; Xu W; Zhang S; Chen J
J Cell Mol Med; 2020 Apr; 24(8):4480-4493. PubMed ID: 32168416
[TBL] [Abstract][Full Text] [Related]
2. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
[TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway.
Liu W; Huang G; Yang Y; Gao R; Zhang S; Kou B
Int J Med Sci; 2021; 18(1):81-87. PubMed ID: 33390776
[TBL] [Abstract][Full Text] [Related]
4. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
5. Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells.
Xu L; Jiang Y; Bi Y; Zheng S; Wu Y; Wu Y; Xu Y; Chen J
Biomed Pharmacother; 2024 Jun; 175():116684. PubMed ID: 38713951
[TBL] [Abstract][Full Text] [Related]
6. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
[TBL] [Abstract][Full Text] [Related]
8. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
9. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract][Full Text] [Related]
10. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells.
Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN
Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487
[TBL] [Abstract][Full Text] [Related]
11. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811
[TBL] [Abstract][Full Text] [Related]
12. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling.
Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM
Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661
[TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits tumor growth in glioma by inducing cell cycle arrest and apoptosis.
Zhang XH; Liu YX; Jia M; Han JS; Zhao M; Ji SP; Li AM
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):29-36. PubMed ID: 25553351
[TBL] [Abstract][Full Text] [Related]
14. Oridonin represses lung cancer cell proliferation and migration by modulating AFAP1-AS1/IGF2BP1.
Chen M; Shen Y
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):108-113. PubMed ID: 38836673
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
16. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
[TBL] [Abstract][Full Text] [Related]
17. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
[TBL] [Abstract][Full Text] [Related]
18. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
[TBL] [Abstract][Full Text] [Related]
19. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
20. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation.
Lin TY; Hsu HY
Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
